Skip to Main Content

WASHINGTON — Executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca, and Novavax will testify Tuesday before the House Energy and Commerce Committee’s oversight arm. The hearing, titled “Pathway to Protection: Expanding Availability of COVID-19 Vaccines,” will give lawmakers a chance to grill drug makers on why supply of Covid-19 vaccines is still so limited — and what they’re doing to fix it.

Here are a few of the burning questions STAT hopes lawmakers will ask.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!